We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 19.00 | 1.07% | 1,799.50 | 1,796.00 | 1,796.50 | 1,799.50 | 1,780.00 | 1,784.00 | 9,804,173 | 16:35:21 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 15.00 | 73.94B |
From May 2019 to May 2024
TIDMGSK
RNS Number : 2134E
GlaxoSmithKline PLC
02 November 2015
GlaxoSmithKline plc (the "Company")
Director Declaration
In conformity with Listing Rule 9.6.14, the Company hereby notifies the market that Dr Stephanie Burns, a Non-Executive Director of the Company, has been appointed as a Director to the Board of HP Inc. with effect from 1 November 2015.
V A Whyte
Company Secretary
2 November 2015
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDNEAAFAELFSFFF
(END) Dow Jones Newswires
November 02, 2015 07:45 ET (12:45 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
